JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fu, L.
Right arrow Articles by Bedwell, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fu, L.
Right arrow Articles by Bedwell, D. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 8, 5431-5440, February 25, 2000


Loss of the Major Isoform of Phosphoglucomutase Results in Altered Calcium Homeostasis in Saccharomyces cerevisiae*

Lianwu FuDagger , Attila MisetaDagger §, Dacia Hunton, Richard B. Marchase, and David M. BedwellDagger ||

From the Departments of Dagger  Microbiology and  Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Phosphoglucomutase (PGM) is a key enzyme in glucose metabolism, where it catalyzes the interconversion of glucose 1-phosphate (Glc-1-P) and glucose 6-phosphate (Glc-6-P). In this study, we make the novel observation that PGM is also involved in the regulation of cellular Ca2+ homeostasis in Saccharomyces cerevisiae. When a strain lacking the major isoform of PGM (pgm2Delta ) was grown on media containing galactose as sole carbon source, its rate of Ca2+ uptake was 5-fold higher than an isogenic wild-type strain. This increased rate of Ca2+ uptake resulted in a 9-fold increase in the steady-state total cellular Ca2+ level. The fraction of cellular Ca2+ located in the exchangeable pool in the pgm2Delta strain was found to be as large as the exchangeable fraction observed in wild-type cells, suggesting that the depletion of Golgi Ca2+ stores is not responsible for the increased rate of Ca2+ uptake. We also found that growth of the pgm2Delta strain on galactose media is inhibited by 10 µM cyclosporin A, suggesting that activation of the calmodulin/calcineurin signaling pathway is required to activate the Ca2+ transporters that sequester the increased cytosolic Ca2+ load caused by this high rate of Ca2+ uptake. We propose that these Ca2+-related alterations are attributable to a reduced metabolic flux between Glc-1-P and Glc-6-P due to a limitation of PGM enzymatic activity in the pgm2Delta strain. Consistent with this hypothesis, we found that this "metabolic bottleneck" resulted in an 8-fold increase in the Glc-1-P level compared with the wild-type strain, while the Glc-6-P and ATP levels were normal. These results suggest that Glc-1-P (or a related metabolite) may participate in the control of Ca2+ uptake from the environment.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Saccharomyces cerevisiae shares many features of Ca2+ homeostasis and signaling pathways with mammals (1). Like other eukaryotes, yeast maintain a low resting free Ca2+ concentration in their cytosol in the range of 50-200 nM (2-5). Considering that the total cellular Ca2+ content is in the millimolar range, more than 99% of the total cell-associated Ca2+ is either bound to proteins within the cytosol or compartmentalized within intracellular organelles. This remarkably tight control of free cytosolic Ca2+ is a universal phenomenon among living organisms that apparently relates to the low solubility of Ca2+ complexes of many phosphorylated metabolites (6). This tight control of free cytosolic Ca2+ is also an essential feature of Ca2+ signaling, where Ca2+-sensing proteins like calmodulin utilize a transient increase in the steady-state cytosolic Ca2+ concentration to activate various signal transduction pathways (7).

The great majority of cellular Ca2+ is stored within intracellular organelles in S. cerevisiae (8). The vacuole is believed to contain the largest (~90%) reservoir of Ca2+, where it is thought to reside primarily in a complex with polyphosphate (9, 10). In contrast, the endoplasmic reticulum (ER)1 and the Golgi apparatus hold Ca2+ in a more readily mobilized form, which, together with cytosolic Ca2+, is often referred to as the exchangeable Ca2+ pool (11). Cytosolic Ca2+ can be transported into the Golgi apparatus by the Ca2+-ATPase Pmr1p (12-15) and possibly by another putative Ca2+ and Mn2+ transporter, Ccc1p (16-18). Consistent with its capacity to store Ca2+, a recent study demonstrated that the Golgi apparatus can play a significant role in maintaining cellular Ca2+ homeostasis under conditions where vacuolar Ca2+ storage is compromised (4). Cytosolic Ca2+ can also be sequestered into the vacuole through the action of the Ca2+-ATPase Pmc1p and the vacuolar H+/Ca2+ exchanger Vcx1p/Hum1p (17, 19, 20). Of these two transporters, Vcx1p has been shown to play a predominant role in pumping cytosolic Ca2+ into the vacuole and restoring basal cytosolic Ca2+ conditions following an increase in cytosolic Ca2+ (5, 17, 20). The expression and function of each of these Ca2+ transporters is regulated by calcineurin, a highly conserved protein phosphatase that is activated by Ca2+/calmodulin (4, 17, 20). While mitochondria have been shown to play an important role in Ca2+ signaling in mammalian cells, there is currently little or no evidence that mitochondria play any role in Ca2+ sequestration in S. cerevisiae (21, 22).

A number of stimuli can trigger a transient increase in the cytosolic Ca2+ concentration in yeast. These stimuli include various nutrients, mating pheromones, or a hypotonic shock (3, 23). While glucose is frequently considered to be primarily a carbon and energy source in yeast, it can also activate several signaling pathways in yeast, including the RAS-cAMP pathway, phosphatidylinositol turnover, Ca2+ influx and efflux, and the glucose repression/de-repression pathway (24). It is unclear whether these distinct pathways are regulated by glucose, a glucose derivative, a glycosylated protein, or by some other mechanism. Eilam and co-workers (25, 26) have shown that glucose-stimulated Ca2+ uptake is not controlled by changes in either the ATP level or by a cAMP-dependent pathway. Interestingly, Glc-6-P has been shown to stimulate the ATP-dependent transport of Ca2+ into mammalian microsomes (27, 28), indicating that glucose metabolites may directly influence Ca2+ transport mechanisms in higher eukaryotes.

The biochemical pathways required to utilize glucose as a carbon and energy source are highly conserved from bacteria to humans. A key enzyme involved in this process is phosphoglucomutase (PGM; EC 2.7.5.1), which catalyzes the interconversion of Glc-1-P and Glc-6-P. PGM acts at a key metabolic trafficking point that controls the synthesis and degradation of carbohydrates. The direction of metabolic flow through PGM depends on the available carbon source. Both the degradation of glycogen and the metabolism of galactose as carbon source require PGM activity to convert Glc-1-P to Glc-6-P. The Glc-6-P produced can then be utilized in glycolysis and the pentose-phosphate shunt. Conversely, PGM mediates the conversion of Glc-6-P to Glc-1-P for sugar nucleotide (and ultimately, cell wall and glycogen) synthesis in cells grown on glucose or non-fermentable carbon sources. S. cerevisiae contains genes encoding two isoforms of PGM. Expression of the PGM2 gene, encoding the major isoform of PGM, is greatly increased in galactose-containing media. In contrast, the PGM1 gene expresses the minor isoform of PGM in a relatively low, constitutive manner (29, 30). Yeast strains that lack both isoforms of PGM are unable to grow when galactose is the sole carbon and energy source (31). However, strains lacking both isoforms of PGM can survive when grown on glucose, apparently because the conversion of Glc-6-P to Glc-1-P can be supported to a small extent by related enzymes such as phosphomannomutase and N-acetylglucosamine-1-phosphate mutase (31, 32).

In the current study, we found that a mutant strain lacking the major isoform of PGM (pgm2Delta ) has a much higher rate of Ca2+ uptake than an isogenic wild-type strain when grown on galactose media. This increased rate of Ca2+ uptake results in a 9-fold increase in total cellular Ca2+, but does not reduce the fraction of Ca2+ located in the exchangeable pool. Consistent with this observation, we could not detect any defect in ER and Golgi functions that have previously been shown to result from an inability to sequester Ca2+ into these compartments in a pmr1Delta strain (12, 13, 33). Interestingly, this Ca2+ hyper-accumulation phenotype is observed only when the pgm2Delta strain is grown in media containing galactose as the sole carbon source, and correlates with the accumulation of Glc-1-P under these growth conditions. These results suggest that Glc-1-P (or a derivative) may regulate Ca2+ uptake from the environment.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Strains Used-- Yeast strains used in this study are listed in Table I. Sc252 and Sc451 were kindly provided by J. Hopper (30). W303-1C and YRP032 were gifts from H. K. Rudolph (33). Yeast strains YDB0171, YDB0200, YDB0322, and YDB0201 were generated using a one-step gene replacement method (34). Briefly, the PGM2 gene in YDB0171, YDB0322, and YDB0201 was disrupted by the insertion of the LEU2 gene. A 1.5-kilobase pair HpaI/HindIII DNA fragment containing most of the structural gene of PGM2 in pDB0197 was removed by the insertion of a BamHI/HindIII fragment containing the LEU2 gene from pJJ282 (35). The PGM1 genes in YDB0200 and YDB0201 were disrupted by the insertion of the URA3 gene. A 2-kilobase pair fragment of the PGM1 gene was generated by polymerase chain reaction using wild-type genomic DNA as template. The forward primer used was DB225 (5'-CAA GAC TCG AGA AGG GCG CAT CAC) and DB226 (5'-GAT CTT GAA TTC CTG TAC GGC TCT GC). These primers contain XhoI and EcoRI restriction endonuclease sites, respectively (underlined). The polymerase chain reaction product was digested with EcoRI and XhoI and cloned into a pBluescript KS II (+) plasmid. The 730-base pair HindIII segment of the PGM1 gene was replaced by the HindIII fragment containing URA3 gene from pJJ244 (35). The EcoRI/XhoI fragment containing the disrupted pgmDelta 1::URA3 was then used to transform yeast. In all cases, the correct gene replacements were confirmed by Southern blot analysis (data not shown). YDB0310 and YDB0312 were generated by backcrossing the Sc451 strain with YR122 (36) by standard methods (37).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Yeast strains used in this study

Culture Medium-- Bacteria strains were grown on standard media (38). Media for yeast growth were prepared as described (37). YP media and synthetic media (SM) was supplemented with 2% glucose (YPD or SMD) or 2% galactose (YPGal or SMGal) All media containing Ca2+ or EGTA were routinely buffered with 40 mM MES-Tris, pH 5.5 or 6.5 as specified. In all experiments, cultures were grown for a minimum of 5-6 generations to an A600 of <= 1.0.

Measurement of Total Cellular Ca2+ Levels, Cytosolic Free Ca2+ Concentration, the Rate of Ca2+ Uptake, and the Efflux of Ca2+-- Total cellular Ca2+ levels were measured as described earlier (4). Briefly, 50-100 OD600 units of yeast cells grown in YPD or YPGal were harvested and washed. The cell pellets were dried in a Savant SpeedVac system and resuspended in 1 M HCl. The total calcium levels were then measured by using a flame photometry method and expressed in moles per kilogram of dry mass.

The cytosolic free Ca2+ was measured by using an aequorin-based method as described (4, 23). Briefly, the cells of the wild-type and pgm2Delta strains containing the apoaequorin-expressing plasmid were grown in SMGal media supplemented with the required amino acids. The cells were then harvested and loaded with coelenterazine. For glucose- or galactose-stimulated Ca2+ uptake, the cells were loaded with coelenterazine, then were incubated without a carbon source for 2 h in SM medium supplemented with 2 mM EGTA. To confirm that the glucose- or galactose-stimulated increase in cytosolic Ca2+ was dependent upon extracellular Ca2+, cells were incubated in the presence or absence of 5 mM CaCl2 for 10 min prior to the addition of glucose or galactose. As previously reported (3), the increase in cytosolic Ca2+ was strictly dependent upon extracellular Ca2+. In these experiments, aequorin luminescence was measured using a Berthold Lumat 9050 luminometer. The data were recorded and transferred to a personal computer for analysis. The cytosolic free Ca2+ was calculated using a standard curve (4).

The rate of Ca2+ uptake was measured as described before (14). The cells were harvested from an exponential phase culture, washed three times with distilled water, and resuspended in a buffer containing 40 mM MES-Tris, pH 5.5, and 20 mM D-glucose. The Ca2+ uptake experiment was then initiated by the addition of [45Ca2+] to a concentration of 1 µCi/ml. At the times indicated, aliquots were filtered through a 0.45-µm Gelman filter pre-washed with buffer containing 20 mM MgCl2 and 0.2 mM LaCl3. The cells were then rapidly washed three times with the same washing solution, and cell-associated [45Ca2+] was determined by scintillation counting. For the measurement of [45Ca2+] uptake in glucose-starved cells, strains were grown in SMGal supplemented with required amino acids and then starved for carbon source for 2 h. The cells were then harvested, washed three times with water, and resuspended in 40 mM MES-Tris buffer, pH 5.5. Ca2+ uptake was initiated by the addition of 1% glucose and 1 µCi of [45Ca2+]. At the indicated times, cells were filtered and washed, and the cell-associated radioactivity was determined by scintillation counting. Nonspecific binding of [45Ca2+] to the cells at the zero time point was subtracted.

The Ca2+ exchange experiments were done as described previously (4, 19). Wild-type and pgm2Delta strains were grown in YPGal for 5-6 generations in the presence of 10 µCi/ml [45Ca2+] before harvest at logarithmic phase. The cells were harvested by centrifugation at room temperature, washed with YP medium, and then resuspended in YPGal plus 20 mM CaCl2. After incubating at 30 °C for the time indicated, aliquots of cells were harvested by rapid filtration, washed, and processed for scintillation counting as described above.

Phosphoglucomutase Assay-- To assay for PGM activity, frozen cell pellets were resuspended to 50 OD600 units/ml in assay buffer (50 mM Bis-Tris, pH 6.0, 150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride). Cells were disrupted by mechanical agitation with glass beads in a mini-bead beater (Biospec Products). Assays were carried out on total cellular homogenates at 22 °C using a coupled enzyme assay as described (29). Specific activity is expressed as micromoles of product formed/min/mg of protein. Protein concentrations were determined by the method of Bradford (39), with bovine serum albumin used to generate the standard curve.

Measure of the Metabolite Levels-- Extracts were made using a method published previously (40). An aliquot of exponentially growing yeast culture was filtered under vacuum through a 0.45-µm Gelman filter. The wet weight of cells was rapidly determined, and the cells were then frozen in liquid nitrogen. 3 ml of 3 M HClO4 was added to the frozen cells, and they were then ground in the presence of glass beads in a mortar cooled with liquid nitrogen. The extract was centrifuged at 4 °C for 10 min at 10,000 × g, and the supernatant was neutralized by the addition of 5 M KClO4. Glc-6-P levels in the extract were measured using an assay coupled with Glc-6-P dehydrogenase (41). Glc-1-P levels were measured similarly, with the addition of PGM. For the calculation of concentrations of each metabolite, it was assumed that 1.67 g of wet yeast contain 1 ml of cell volume (40).

The levels of ATP, ADP, and AMP were measured by high performance liquid chromatography analysis. Briefly, yeast extracts were resolved using a Keystone Partisil-10 SAX column using a linear salt and pH gradient from 5 to 750 mM (NH4)H2PO4 and from pH 2.8 to 3.7, respectively, at a flow rate of 2 ml/min over 40 min. External standards of known concentration were used to identify and quantitate specific peaks that corresponded to each metabolite. The energy charge of each strain was calculated as the sum of the ATP concentration plus one-half the ADP concentration divided by the sum of the concentrations of ATP, ADP, and AMP.

Analysis of Invertase Glycosylation and CpY* Degradation-- Invertase glycosylation was determined from cells labeled with [35S] methionine/cysteine (Expre35S35S; NEN Life Science Products). Immunoprecipitation was carried out using an invertase antibody (a gift from Scott Emr) as described previously (42). To amplify the invertase signal, strains containing pRB58 (43), a high copy invertase-expressing plasmid, were grown in SMGal medium supplemented with the required amino acids. 10 A600 units of cells were used for the initial immunoprecipitation, followed by a second immunoprecipitation using the same antibody. CpY* degradation was assayed by a pulse-chase experiment as described previously (33), except the cells were grown in SMGal medium.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Growth Phenotype of a pgm2Delta Yeast Strain-- PGM is a key enzyme in glucose and galactose metabolism. In S. cerevisiae there are two isoforms of PGM that are subject to distinct patterns of regulation (29, 30). To better understand the physiological roles of PGM, we constructed strains containing single pgm1Delta or pgm2Delta knockouts, as well as a strain containing knockouts of both genes (pgm1Delta /pgm2Delta ). Initially, we compared the growth of these strains on YPD and YPGal media. Consistent with the results reported by Boles et al. (31), the pgm1Delta , pgm2Delta , and pgm1Delta /pgm2Delta strains could all grow as well as the WT strain in YPD medium (data not shown). On YPGal medium, the pgm1Delta strain grew as well as the WT strain, while the growth of the pgm2Delta mutant was somewhat reduced. In contrast, the pgm1Delta /pgm2Delta strain could not grow on YPGal media, confirming that PGM activity is essential for growth when galactose is the sole carbon source (31).

The pgm2Delta Strain Accumulates Glc-1-P When Grown on Galactose Media-- PGM catalyzes the interconversion of Glc-6-P and Glc-1-P. To determine how the pgm1Delta and pgm2Delta mutations affect the levels of sugar metabolites and energy metabolism in cells grown on galactose media, we measured the specific activity of PGM and the concentrations of Glc-1-P and Glc-6-P in strains containing deletions of each PGM gene. As shown in Fig. 1A, inactivation of the PGM2 gene greatly reduced the enzymatic activity of PGM in galactose-grown cells. The specific activity of PGM in the WT strain was about 0.9 µmol/min/mg of protein, while the pgm2Delta mutant was about 0.03 µmol/min/mg of protein. Thus, the pgm2Delta mutant has 30-fold less PGM activity than the WT strain.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Measurement of PGM specific activity, glucose metabolites, and energy charge. Following growth in YPGal media to mid-log phase, cells were harvested and extracts were prepared as indicated under "Materials and Methods." A, PGM specific activity in the WT and pgm2Delta strain. B, Glc-1-P and Glc-6-P levels in the WT and pgm2Delta strain. C, energy charge measured in the WT and pgm2Delta strains.

We next measured the levels of Glc-6-P and Glc-1-P in these strains. We found that the steady-state levels of Glc-6-P and Glc-1-P in the WT strain were 0.23 and 0.11 mM, respectively, when the cells were grown in galactose-containing media. While the pgm2Delta strain had a level of Glc-6-P that was not significantly different from the WT strain (0.20 mM), the Glc-1-P level in this strain was increased to 0.75 mM (Fig. 1B). Hence, the intracellular Glc-1-P concentration was 7-fold higher in the pgm2Delta mutant than in the WT strain. These results suggest that the limitation of PGM enzymatic activity caused by the pgm2Delta mutation results in a metabolic bottleneck that restricts the conversion of Glc-1-P to Glc-6-P. Like the Glc-6-P level, the cellular energy charge in these strains was also found to be similar (Fig. 1C), indicating that the pgm2Delta mutation did not cause a reduction in the ATP level when galactose was utilized as the carbon source. Since the pgm2Delta strain exhibits a moderately slower growth rate than the WT strain, these results suggest that cellular growth may be limited by the ability to generate a normal level of Glc-6-P (and ultimately, ATP). In contrast, no significant differences in the levels of Glc-1-P, Glc-6-P, or the energy charge were measured in these strains when they were grown in YPD media (data not shown).

The pgm2Delta Strain Contains an Elevated Level of Total Cellular Ca2+-- Previous studies have shown that glucose can transiently stimulate Ca2+ uptake in glucose-deprived yeast cells (3, 26). In addition, glucose can induce phosphatidylinositol turnover and activation of the plasma membrane H+-ATPase in glucose-deprived cells (24). While the mechanism by which glucose activates these (and other) signaling pathways is not well understood, it is thought that glucose or phosphorylated glucose derivatives may be responsible. This led us to ask whether an alteration in the concentration of glucose metabolites such as those observed in the pgm2Delta strain when grown on YPGal could lead to an imbalance in Ca2+ homeostasis. We initially measured the total cellular Ca2+ level in the WT and pgm2Delta strains by flame photometry (4). We found that the total cellular Ca2+ level in the WT strain was 2.85 mmol/kg dry weight (Fig. 2A). In contrast, the pgm2Delta mutant contained 25.83 mmol of Ca2+/kg dry weight. Thus, the amount of total cellular Ca2+ in the pgm2Delta strain was 9-fold higher than the wild-type strain in YPGal medium. We confirmed that the pgm2Delta strain had a much higher level of total cellular Ca2+ by measuring the accumulation of [45Ca2+] (data not shown). When these strains were grown on YPD medium, we did not observe a significant difference in the total cellular Ca2+ levels between the WT and pgm2Delta strains, which contained 2.40 and 2.56 mmol of Ca2+/kg of dry weight, respectively (Fig. 2B). These results indicate that the increased accumulation of cellular Ca2+ in the pgm2Delta mutant is dependent upon utilization of galactose as the carbon source.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Total cellular Ca2+ accumulation and uptake. A, total cellular Ca2+ in strains grown in YPGal medium. B, total cellular Ca2+ in strains grown in YPD medium. The indicated strains were grown in standard YP medium supplemented with the indicated carbon source to a density of ~1 OD600/ml. 100 OD600 units of cells were harvested and washed with fresh YP. Total Ca2+ was then determined by flame photometry as described (4). C, measurement of Ca2+ uptake rates. The rate of [45Ca2+] uptake was measured in the indicated strains over a time interval of 60 s as described under "Materials and Methods."

The yeast PMR1 gene encodes a P-type Ca2+-ATPase that localizes to the Golgi membrane (13). Previous studies have documented the role of Pmr1p in Ca2+ transport into the Golgi apparatus (12, 14) and in the maintenance of cellular Ca2+ homeostasis in yeast (4). It has been reported that the total cellular Ca2+ level in the pmr1Delta strain is increased 5-10-fold compared with the WT strain when grown on YPD medium (14). Consistent with these reports, we found that the pmr1Delta strain grown in YPD medium contained 20.91 mmol of Ca2+/kg of dry weight, a level that was 8.7-fold higher than the WT strain (Fig. 2B). When the pmr1Delta strain was grown in YPGal medium, we found that the total cellular Ca2+ level was 7.85 mmol/kg dry mass, a level that was 2.7-fold lower than was observed in cells grown in YPD (Fig. 2A). This observation suggests that the carbon source may also have a moderate effect on the absolute level of Ca2+ accumulation in the pmr1Delta strain. However, only the pgm2Delta mutant showed a conditional defect in Ca2+ accumulation that was evident only when a specific carbon source was utilized.

Ca2+ Uptake Is Increased in the pgm2Delta Strain-- The massive Ca2+ accumulation observed when the pgm2Delta mutant was grown in YPGal suggested that the rate of Ca2+ uptake might also be increased. According to Eilam and co-workers (44), the time course of Ca2+ influx into yeast is composed of two components. The initial component represents Ca2+ transported across the plasma membrane into the cytosol. The second component represents the subsequent distribution of the cytosolic Ca2+ into intracellular organelles. These two components of Ca2+ uptake can be determined by measuring [45Ca2+] uptake during short and long time intervals, respectively. Yeast cells were grown in YPGal and [45Ca2+] uptake experiments were done as described (14, 44). We found that the initial [45Ca2+] uptake rate in the pgm2Delta strain was 5 times faster than was observed in the WT strain, indicating that the elevated Ca2+ accumulation in the pgm2Delta strain correlates well with an increase in the rate of Ca2+ uptake across the cytoplasmic membrane (Fig. 2C). By comparison, under the same conditions, we found that Ca2+ uptake by the pmr1Delta strain was only 2-fold greater than the WT strain. These values correlate well with the total cellular Ca2+ levels measured in each of these mutant strains.

The Fraction of Total Cellular Ca2+ in the Exchangeable Pool Is Not Reduced in the pgm2Delta Strain-- Intracellular Ca2+ in yeast exists in two kinetically distinguishable pools, the exchangeable pool (representing Ca2+ in the cytosol, ER, and Golgi apparatus) and the non-exchangeable pool (representing Ca2+ in a more stable form within the vacuole) (19, 45). To determine whether the partitioning of cellular Ca2+ between the exchangeable and non-exchangeable pools is altered in the pgm2Delta strain, cells growing in YPGal medium were loaded for several generations with [45Ca2+]. They were then harvested, resuspended in YPGal containing 20 mM CaCl2, and the radioactivity that remained associated with cells was determined as a function of time (Fig. 3). Under these conditions, ~13% of the total cellular [45Ca2+] was measured in the exchangeable pool in WT cells after 40 min, while the remaining 87% of cellular [45Ca2+] was located within the non-exchangeable pool (Fig. 3C).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Measurement of the exchangeable and non-exchangeable pools by [45Ca2+] release. The indicated strains were grown for five generations in YPGal medium supplemented with [45Ca2+]. To initiate the release of cellular [45Ca2+], the strains were harvested, washed, and resuspended in YPGal supplemented with 20 mM CaCl2. The cultures were then incubated at 30 °C, and aliquots of cells were harvested at the indicated times. The amount of cell-associated [45Ca2+] was determined by liquid scintillation counting. A, non-exchangeable pools, as measured by [45Ca2+] associated with cells after 40 min of incubation. B, exchangeable pools, as measured by [45Ca2+] released from cells after 40 min of incubation. C, percentage of cell-associated [45Ca2+] that remained at the indicated times.

Since the pmr1Delta strain contains a much larger absolute amount of cellular Ca2+ than the WT strain, it also contains more Ca2+ in both the non-exchangeable and exchangeable pools (Fig. 3, A and B, respectively). However, a much smaller fraction of the total cellular Ca2+ (~7%) was found in the exchangeable pool in the pmr1Delta mutant, consistent with its reduced ability to transport Ca2+ into the ER and Golgi (Fig. 3C) (12, 13, 33). Like the pmr1Delta strain, the pgm2Delta strain also contains more total cellular Ca2+ than the WT strain. Consequently, the amount of Ca2+ present in both the non-exchangeable and exchangeable pools in this strain was also larger than was observed in the WT strain (Fig. 3, A and B). However, the absolute amount of Ca2+ present in the exchangeable pool of the pgm2Delta strain was >4-fold larger than was observed in the pmr1Delta strain. Accordingly, the percentage of exchangeable Ca2+ in the pgm2Delta mutant (~20%) was also much higher than the pmr1Delta strain (and actually somewhat higher than the WT strain). These results indicate that the pgm2Delta strain does not have a diminished capacity to maintain cellular Ca2+ in the exchangeable pool (which includes the ER and/or Golgi), as was previously shown for the pmr1Delta strain.

Galactose Metabolism Blocks Growth of a pgm2Delta /pmr1Delta Double Mutant-- To gain a better understanding of the relationship between Pgm2p and Pmr1p in the maintenance of Ca2+ homeostasis, we generated a pgm2Delta /pmr1Delta double mutant. While strains carrying the pgm2Delta or pmr1Delta mutations alone were able to grow on YPGal plates, the pgm2Delta /pmr1Delta double mutant was unable to grow on galactose-containing media (Fig. 4A). Interestingly, the growth inhibition of the pgm2Delta /pmr1Delta double mutant was relieved by the addition of 100 mM CaCl2 to the medium (Fig. 4B). This conditional synthetic lethality associated with combining the pmr1Delta and pgm2Delta mutations suggests that the defects associated with these mutations are additive in nature.


View larger version (194K):
[in this window]
[in a new window]
 
Fig. 4.   The pgm2Delta /pmr1Delta strain is unable to grow in galactose-containing medium. The strains indicated were plated on YPGal (A), YPGal plus 100 mM CaCl2 (B), YPLactate (C), and YPGal plus lactate (D). The plates were incubated at 30 °C for 5-7 days.

There are two possible reasons why the pgm2Delta /pmr1Delta double mutant is unable to grow on media containing galactose as carbon source. First, the cells may not grow because they are unable to utilize galactose as the sole carbon and energy source available in the medium. Alternatively, the metabolism of galactose may lead to such a severe imbalance in cellular physiology that growth is inhibited. To distinguish between these possibilities, the cells were inoculated onto YP plates containing either lactate or lactate and galactose as carbon source(s). We found that each of the mutant strains (pgm2Delta , pmr1Delta , and pgm2Delta /pmr1Delta ) and the WT strain were able to grow when lactate alone was provided as sole carbon source (Fig. 4C). When both galactose and lactate were present, the WT and each of the single mutants were again able to grow. In contrast, the pgm2Delta /pmr1Delta double mutant was unable to grow under these conditions (Fig. 4D), indicating that the metabolism of galactose disrupted cellular physiology (presumably Ca2+ homeostasis) to the extent that growth could not occur even through the utilization of lactate as carbon source.

The pgm2Delta Strain Is Sensitive to Cyclosporin A When Grown in Galactose-containing Media-- Under normal conditions, the cytosolic Ca2+ concentration in yeast is maintained within the 50-200 nM range (2, 3). Since we observed an elevated level of total Ca2+ and exchangeable Ca2+ in the pgm2Delta strain when grown in galactose-containing media, we next asked whether the signaling pathway mediated by calcineurin and calmodulin was activated. To test this possibility, we asked whether each of these strains could grow on YPGal medium in the presence of 10 µg/ml cyclosporin A (CsA), an inhibitor of calcineurin. We found that growth of the WT and pmr1Delta strains was unaffected by CsA, while growth of the pgm2Delta strain was completely inhibited (Fig. 5). These results suggests that the pgm2Delta mutation may cause an imbalance in cellular Ca2+ homeostasis to the extent that activation of the calcineurin pathway is required to maintain growth of the pgm2Delta strain in galactose-containing media.


View larger version (92K):
[in this window]
[in a new window]
 
Fig. 5.   Growth of the pgm2Delta strain is inhibited by CsA. Strains were streaked onto YPGal (A) and YPGal supplemented with 10 µg/ml CsA (B).

The pgm2Delta Mutation Leads to Increased Sequestration of Cytosolic Ca2+ into Intracellular Compartments-- In a previous study, it was shown that the re-addition of glucose to glucose-starved cells led to a transient increase in cytosolic Ca2+ that was dependent upon the presence of extracellular Ca2+ (3). Since our CsA experiment indicated that the pgm2Delta strain required constitutive calcineurin activity to grow in galactose media, we next asked whether this state of calcineurin activation could reduce or abolish the increase in cytosolic Ca2+ levels previously shown to accompany the addition of glucose to glucose-starved cells. To make these measurements, we utilized an aequorin reporter system (23, 46) that recently proved useful in measuring transient changes in the cytosolic Ca2+ concentration of yeast (4, 5). An aequorin expression plasmid was transformed into the WT and pgm2Delta strains, and cultures of each strain were grown in SMGal medium to mid-log phase. The cells were then harvested and resuspended in SM medium lacking a carbon source for 2 h. We found that the resting concentration of cytosolic Ca2+ in the WT strain was ~100 nM. When glucose was injected into the chamber to a final concentration of 1%, we found that the cytosolic Ca2+ began to rise after a lag of 40-60 s and reached a peak of ~340 nM within 2-3 min (Fig. 6A). The Ca2+ level then dropped over the next 5 min until it reached a basal cytosolic Ca2+ concentration similar to the level measured before glucose addition.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   The pgm2Delta strain is defective in glucose-induced Ca2+ signaling. The carbon source re-added was 1% glucose (A) or 1% galactose (B). Yeast cells of the wild-type or the pgm2Delta strain, which were transformed previously with apoaequorin-containing plasmid, were grown in SMGal, loaded with coelenterazine, and starved for carbon source for 2 h. The indicated carbon source was then added (as indicated by the arrow). The rate of [45Ca2+] uptake following the addition of 1% glucose is shown in C.

When we repeated this protocol with the pgm2Delta strain, we found that the unstimulated cytosolic Ca2+ concentration after carbon source depletion was ~90 nM, slightly lower than the WT strain. However, when glucose was added to the carbon source-starved pgm2Delta strain, no increase in cytosolic Ca2+ was observed. To confirm that this absence of glucose-stimulated Ca2+ uptake was not due to the fact that the strains were grown in SMGal medium, we repeated the experiment and examined the effect of galactose addition following the starvation period. With the WT strain, we measured a basal cytosolic Ca2+ concentration of ~60 nM. When galactose was added, we again observed a 40-60-s delay, followed by a rapid increase in cytosolic Ca2+ that reached a peak of ~160 nM. With the pgm2Delta strain, we observed a resting cytosolic Ca2+ concentration of ~50 nM (again, slightly lower than the WT strain). When galactose was added to the starved pgm2Delta cells, we observed a very slight increase in cytosolic Ca2+ to ~60 nM, but the response was still much smaller than was observed in the WT strain (Fig. 6B).

The results of the above experiments indicate that the pgm2Delta strain is either unable to carry out Ca2+ uptake from the extracellular environment under these conditions, or it removes Ca2+ from its cytosol so rapidly that the cytosolic Ca2+ concentration cannot increase to the level observed in the WT strain. To distinguish between these possibilities, we used a similar experimental protocol to determine whether [45Ca2+] uptake was altered in the pgm2Delta strain. Cells were grown in SMGal medium, harvested, and resuspended in SM lacking a carbon source for 2 h. The rate of [45Ca2+] uptake was then measured upon the re-addition of glucose to the medium. We found that both strains had similar rates of [45Ca2+] uptake (Fig. 6C), indicating that the pgm2Delta strain was not significantly different from the WT strain in its ability to take up Ca2+ following carbon source starvation. We conclude that the transient rise in cytosolic Ca2+ was not observed in the pgm2Delta strain upon glucose addition because the entering Ca2+ was rapidly sequestered into intracellular compartments. This increased rate of Ca2+ sequestration is presumably mediated by Ca2+ transporters activated by calcineurin in response to the elevated influx of Ca2+ in the pgm2Delta stain.

The pgm2Delta Mutation Does Not Affect Ca2+-dependent ER and Golgi Functions-- The PMR1 gene encodes a Ca2+-ATPase localized to the Golgi membrane (12). Although a direct measurement of the Golgi Ca2+ level has not been made in the pmr1Delta mutant, the size of its exchangeable Ca2+ pool is reduced in a manner that is consistent with reduced Golgi Ca2+ levels. Furthermore, the pmr1Delta mutation results in incomplete outer chain glycosylation of invertase, a process that is carried out by enzymes in the Golgi compartment (12, 13). Recently, it was shown that deletion of the PMR1 gene also results in a delayed degradation of CpY*, a mutant form of the vacuolar protein carboxypeptidase Y (CpY) that is unable to acquire a properly folded conformation upon translocation across the ER membrane (33). As a consequence, it is recognized by the quality control apparatus within the ER and rapidly transported back out of the ER to proteosomes for degradation (47, 48). The pgm2Delta mutant shares some alterations in Ca2+ homeostasis with the pmr1Delta strain, such as an elevated total cellular Ca2+ level and increased Ca2+ uptake. On the other hand, the pgm2Delta mutant (unlike the pmr1Delta mutant) retains a normal distribution of Ca2+ between the exchangeable and non-exchangeable pools.

To determine whether the pgm2Delta mutation also affects the retrograde transport of misfolded proteins from the ER like the pmr1Delta mutation, we determined the rate of CpY* degradation by pulse-chase analysis of strains grown on SMGal medium. The WT strain was found to degrade CpY* with a half-life of 20 min, while the degradation of CpY* in the pmr1Delta strain had a half-life of ~80 min (Fig. 7, A and B). This delay in degradation in the pmr1Delta strain is similar to the previously reported decay kinetics of CpY* in this mutant (33). In contrast, the degradation of CpY* in the pgm2Delta strain occurred at a rate similar to the WT strain, indicating that the pgm2Delta mutation did not affect the retrograde transport of CpY* from the ER to the cytosol.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 7.   Measurement of CpY* degradation and invertase glycosylation. A, the strains indicated were grown in SMGal, labeled with [35S]methionine, and chased with an excess of methionine and cysteine for the indicated times. CpY* was analyzed by immunoprecipitation with antiserum specific to yeast CpY. B, quantitation of [35S]methionine-labeled CpY* that remained after the indicated chase period. C, the strains indicated were labeled with [35S]methionine in SMGal. Invertase was then immunoprecipitated with a rabbit polyclonal antiserum and analyzed by SDS-polyacrylamide gel electrophoresis. The secreted and ER forms of invertase are indicated.

Since the pmr1Delta mutation also results in incomplete outer chain glycosylation of invertase during its transit through the Golgi apparatus, we also examined the glycosylation state of invertase in the pgm2Delta strain following growth on SMGal medium. As shown in Fig. 7C, the pmr1Delta strain lacks the heterogeneous, highly glycosylated form invertase that migrates as a smear above the ER form. In contrast, invertase in the pgm2Delta mutant was glycosylated in a manner similar to the WT strain, indicating that glycosylation within the Golgi is not significantly altered by the pgm2Delta mutation. We conclude that the pgm2Delta mutation does not alter the Ca2+ concentration within the ER and Golgi compartments to the extent that these enzymatic processes are compromised.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The results of this study indicate that the loss of the major isoform of PGM causes large alterations in cellular Ca2+ homeostasis and signaling in galactose-grown cells. Under these conditions, the pgm2Delta strain exhibited a much higher rate of Ca2+ uptake and more total cellular Ca2+ than the WT strain. The pgm2Delta strain was unable to grow on YPGal plates supplemented with CsA, suggesting that the activation of Ca2+ transporters by the calcineurin pathway may be required to adequately sequester the large quantity of Ca2+ that enters the cytosol of these cells. Such an increased capacity to rapidly remove cytosolic Ca2+ could also explain why the pgm2Delta strain is unable to properly mediate the transient increase in cytosolic Ca2+ that accompanies the addition of glucose to glucose-starved cells as described in previous studies (3, 26). In contrast, we did not observe any of these Ca2+-related alterations when the pgm2Delta strain was grown in either glucose or lactate media. The pgm2Delta strain thus exhibits a carbon source-dependent defect in both cellular Ca2+ homeostasis and signaling. Since the normal enzymatic function of PGM is to inter-convert Glc-1-P and Glc-6-P, the loss of the majority of cellular PGM activity could be predicted to limit the conversion of Glc-1-P to Glc-6-P in cells grown on galactose, resulting in a "metabolic bottleneck." Consistent with this prediction, we found that the pgm2Delta strain accumulates a large amount of Glc-1-P when grown on galactose media. The simplest interpretation of these results is that the intracellular level of Glc-1-P (or a related glucose metabolite) stimulates the accumulation of Ca2+ in the pgm2Delta strain under these conditions. Interestingly, we found that the total cellular Ca2+ level in the pmr1Delta strain was 2.5-fold higher when grown in YPD medium than in YPGal, providing further evidence that glucose metabolites may play a more general role in controlling cellular Ca2+ levels than was previously appreciated.

The PMR1 gene encodes a Ca2+-ATPase involved in the transport of Ca2+ into the Golgi apparatus. Several of the Ca2+-related defects of the pgm2Delta strain grown in galactose-containing media are similar to those observed with the pmr1Delta strain, including elevated Ca2+ uptake and accumulation (12-14). Durr and co-workers (33) proposed that Pmr1p also mediates the uptake of Ca2+ into the ER, since the pmr1Delta strain also exhibits a defect in retrograde protein transport out of the ER. In certain mammalian cell types, the depletion of Ca2+ stores within the ER has been proposed to induce the synthesis of a diffusible molecule termed calcium influx factor (CIF). This molecule is thought to stimulate the uptake of Ca2+ across the plasma membrane to amplify and prolong the propagation of the cytosolic Ca2+ signal. Interestingly, the yeast pmr1Delta strain is missing the Ca2+-ATPase responsible for transporting Ca2+ into the ER and the Golgi apparatus, and it also exhibits an increased rate of Ca2+ uptake and accumulation. This phenotype would be predicted if the depletion of Ca2+ from the compartments of the secretory pathway resulted in the production of a CIF-like molecule. Consistent with this reasoning, a recent study found that this strain produces a high level of a CIF-like activity (49). Several groups have reported that CIF is a soluble molecule with a molecular mass of <= 700 Da (49-51). Although the structure of CIF has not been determined, it was suggested to contain hydroxyl groups on adjacent carbons and a phosphate moiety (51, 52). The predicted molecular mass and structural characteristics are consistent with the features expected if CIF were related to (or derived from) a sugar phosphate or sugar nucleotide (53). This raises the possibility that Glc-1-P may be a metabolic precursor in the CIF biosynthetic pathway.

While the increased rate of Ca2+ uptake and total cellular Ca2+ levels in the pgm2Delta strain could be attributable to a store depletion mechanism that involves a CIF-like signaling molecule, other aspects of the phenotype of the pgm2Delta strain are inconsistent with such a model. First, our data indicate that the pgm2Delta strain, unlike the pmr1Delta strain, contains a fraction of total cellular Ca2+ in the exchangeable pool that is at least as large (if not larger) than the exchangeable pool in the WT strain. This suggests that the level of Ca2+ contained in the ER and the Golgi apparatus is not significantly reduced. Consistent with this, we did not observe any evidence of reduced Ca2+ levels within the ER or Golgi apparatus of the pgm2Delta strain in functional assays that measured retrograde transport of CpY* from the ER, or invertase glycosylation in the Golgi apparatus. These results indicate that the elevated rate of Ca2+ uptake in the pgm2Delta strain is not coupled to a defect in filling the Ca2+ stores within the ER and/or the Golgi apparatus. Instead, it appears that the pmr1Delta and pgm2Delta mutations induce the uptake of Ca2+ in mechanistically distinct ways. Since the pgm2Delta strain accumulates a high level of Glc-1-P, we hypothesize that Glc-1-P accumulation may be coupled to elevated Ca2+ uptake by some mechanism. It is possible that the accumulation of Glc-1-P may bypass the need to deplete ER or Golgi Ca2+ stores prior to increased Ca2+ uptake. This could occur if an increased concentration of Glc-1-P stimulates the synthesis of CIF in the absence of store depletion, or if Glc-1-P directly stimulates the rate of Ca2+ accumulation into one or more intracellular compartments (such as the ER, Golgi apparatus, or vacuole). This latter possibility would not be unprecedented, since it has been shown that Glc-6-P can stimulate ATP-dependent Ca2+ uptake into isolated mammalian microsomes (27, 28). The existence of a Glc-6-P transporter in mammalian ER membranes is well established. While Glc-6-P transporter activity in the ER is coupled to Glc-6-P phosphatase activity in the ER lumen of gluconeogenic tissues such as liver, the much broader tissue distribution of the Glc-6-P transporter suggests that it may also participate in another general cellular process such as Ca2+ homeostasis (54). Consistent with this, it has been shown that neutrophils and monocytes from patients with Glc-6-P transporter deficiency are unable to efficiently sequester Ca2+ (55). As would be predicted from our model that Glc-1-P can also function in this way, it was recently found that Glc-1-P can also stimulate the ATP-dependent uptake of Ca2+ into isolated cardiac microsomes.2

To better understand how Pgm2p and Pmr1p each influence cellular Ca2+ homeostasis, we constructed a pgm2Delta /pmr1Delta strain. To our surprise, the pgm2Delta /pmr1Delta double mutant was unable to grow on YPGal medium, even when an alternate carbon source (lactate) was present. This suggests that the metabolism of galactose in the pgm2Delta /pmr1Delta double mutant may cause such a severe imbalance in ion homeostasis that cell growth is inhibited. This finding again suggests that the pmr1Delta and pgm2Delta mutations may increase Ca2+ uptake in distinct ways, since the phenotypic consequences of combining these two mutations were more severe than the phenotype of strains carrying either mutation alone. Although our results indicate that the free Ca2+ level within the ER and the Golgi apparatus is normal in the pgm2Delta strain, we cannot exclude the possibility that the elevated Ca2+ uptake associated with the pgm2Delta mutation is caused by the inability to fill another intracellular compartment (or subcompartment) with Ca2+. If this were the case, the combination of the pgm2Delta and pmr1Delta mutations could further compromise the ability to adequately fill the effected compartments when grown in standard YPGal medium (which contains only 0.3 mM Ca2+). Our finding that the addition of 100 mM CaCl2 can restore the growth of the pgm2Delta /pmr1Delta strain on this growth medium is consistent with such a model. Clearly, further studies are required to determine the mechanism that couples glucose metabolism to Ca2+ homeostasis. The elucidation of this process may provide important new insights into the control of Ca2+ homeostasis in yeast. Ultimately, it may also lead to a better understanding of human diseases such as diabetes that are also caused by defects in glucose metabolism.

    ACKNOWLEDGEMENTS

We thank Dr. James Hopper, Dr. Hans K. Rudolph, and Dr. Todd R. Graham for providing strains and plasmids; Dr. Scott Emr for antiserum; and Dr. Richard Kellermayer for helpful discussions and for critically reading the manuscript.

    FOOTNOTES

* This work was supported by Grant JDF 99502 from the Juvenile Diabetes Foundation International.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Present address: Dept. of Clinical Chemistry, University Medical School, 7624 Pecs, Hungary.

|| To whom correspondence should be addressed: Dept. of Microbiology, Bevill Biomedical Research Bldg., Rm. 432, 845 19th St. S., University of Alabama at Birmingham, Birmingham, AL 35294-2170. Tel.: 205-934-6593; Fax: 205-975-5482; E-mail: dbedwell@uab.edu.

2 R. Marchase, unpublished results.

    ABBREVIATIONS

The abbreviations used are: ER , endoplasmic reticulum; WT, wild-type; Glc-1-P, glucose 1-phosphate; Glc-6-P, glucose 6-phosphate; CsA, cyclosporin A; MES, 2-(N-morpholino)ethane sulfonic acid; Bis-Tris, bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane; CpY, carboxypeptidase Y; PGM, phosphoglucomutase; CIF, calcium influx factor; SM, synthetic medium.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Cunningham, K. W., and Fink, G. R. (1994) J. Exp. Biol. 196, 157-166[Abstract/Free Full Text]
2. Iida, H., Yagawa, Y., and Anraku, Y. (1990) J. Biol. Chem. 265, 13391-13399[Abstract/Free Full Text]
3. Nakajima-Shimada, J., Iida, H., Tsuji, F. I., and Anraku, Y. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6878-6882[Abstract/Free Full Text]
4. Miseta, A., Fu, L., Kellermayer, R., Buckley, J., and Bedwell, D. M. (1999) J. Biol. Chem. 274, 5939-5947[Abstract/Free Full Text]
5. Miseta, A., Kellermayer, R., Aiello, D. P., Fu, L., and Bedwell, D. M. (1999) FEBS Lett. 451, 132-136[CrossRef][Medline] [Order article via Infotrieve]
6. Williams, R. J. (1990) Adv. Exp. Med. Biol. 269, 7-16[Medline] [Order article via Infotrieve]
7. Putney, J. W., Jr., and Bird, G. S. J. (1993) Cell 75, 199-201[CrossRef][Medline] [Order article via Infotrieve]
8. Halachmi, D., and Eilam, Y. (1989) FEBS Lett. 256, 55-61[CrossRef][Medline] [Order article via Infotrieve]
9. Eilam, Y., Lavi, H., and Grossowicz, N. (1985) J. Gen. Microbiol. 131, 623-629
10. Ohsumi, Y., Kitamoto, K., and Anraku, Y. (1988) J. Bacteriol. 170, 2676-2682[Abstract/Free Full Text]
11. Cunningham, K. W., and Fink, G. R. (1994) J. Cell Biol. 124, 351-363[Abstract/Free Full Text]
12. Antebi, A., and Fink, G. R. (1992) Mol. Biol. Cell 3, 633-654[Abstract]
13. Rudolph, H. K., Antebi, A., Fink, G. R., Buckley, C. M., Dorman, T. E., LeVitre, J., Davidow, L. S., Mao, J. I., and Moir, D. T. (1989) Cell 58, 133-145[CrossRef][Medline] [Order article via Infotrieve]
14. Halachmi, D., and Eilam, Y. (1996) FEBS Lett. 392, 194-200[CrossRef][Medline] [Order article via Infotrieve]
15. Sorin, A., Rosas, G., and Rao, R. (1997) J. Biol. Chem. 272, 9895-9901[Abstract/Free Full Text]
16. Fu, D., Beeler, T., and Dunn, T. (1994) Yeast 10, 515-521[CrossRef][Medline] [Order article via Infotrieve]
17. Pozos, T. C., Sekler, I., and Cyert, M. S. (1996) Mol. Cell. Biol. 16, 3730-3741[Abstract/Free Full Text]
18. Lapinskas, P. J., Lin, S. J., and Culotta, V. C. (1996) Mol. Microbiol. 21, 519-528[CrossRef][Medline] [Order article via Infotrieve]
19. Cunningham, K. W., and Fink, G. R. (1994) J. Cell Biol. 124, 351-363
20. Cunningham, K. W., and Fink, G. R. (1996) Mol. Cell. Biol. 16, 2226-2237[Abstract]
21. Pinton, P., Brini, M., Bastianutto, C., Tuft, R. A., Pozzan, T., and Rizzuto, R. (1998) Biofactors 8, 243-253[Medline] [Order article via Infotrieve]
22. Uribe, S., Rangel, P., and Pardo, J. P. (1992) Cell Calcium 13, 211-217[CrossRef][Medline] [Order article via Infotrieve]
23. Batiza, A. F., Schulz, T., and Masson, P. H. (1996) J. Biol. Chem. 271, 23357-23362[Abstract/Free Full Text]
24. Thevelein, J. M., and Hohmann, S. (1995) Trends Biochem. Sci. 20, 3-10[CrossRef][Medline] [Order article via Infotrieve]
25. Eilam, Y., and Othman, M. (1990) J. Gen. Microbiol. 136, 861-866[Medline] [Order article via Infotrieve]
26. Eilam, Y., Othman, M., and Halachmi, D. (1990) J. Gen. Microbiol. 136, 2537-2543[Medline] [Order article via Infotrieve]
27. Benedetti, A., Fulceri, R., Romani, A., and Comporti, M. (1988) J. Biol. Chem. 263, 3466-3473[Abstract/Free Full Text]
28. Chen, P. Y., Csutora, P., Veyna-Burke, N. A., and Marchase, R. B. (1998) Diabetes 47, 874-881[Abstract]
29. Fu, L., Bounelis, P., Dey, N., Browne, B. L., Marchase, R. B., and Bedwell, D. M. (1995) J. Bacteriol. 177, 3087-3094[Abstract/Free Full Text]
30. Oh, D., and Hopper, J. E. (1990) Mol. Cell. Biol. 10, 3373-3377
31. Boles, E., Liebetrau, W., Hofmann, M., and Zimmermann, F. K. (1994) Eur. J. Biochem. 220, 83-96[Medline] [Order article via Infotrieve]
32. Hofmann, M., Boles, E., and Zimmermann, F. K. (1994) Eur. J. Biochem. 221, 741-747[Medli